146 related articles for article (PubMed ID: 27585955)
1. 3'-hydroxy-3,4,5,4'-tetramethoxystilbene, the metabolite of resveratrol analogue DMU-212, inhibits ovarian cancer cell growth in vitro and in a mice xenograft model.
Piotrowska-Kempisty H; Ruciński M; Borys S; Kucińska M; Kaczmarek M; Zawierucha P; Wierzchowski M; Łażewski D; Murias M; Jodynis-Liebert J
Sci Rep; 2016 Sep; 6():32627. PubMed ID: 27585955
[TBL] [Abstract][Full Text] [Related]
2. DMU-212 inhibits tumor growth in xenograft model of human ovarian cancer.
Piotrowska H; Myszkowski K; Abraszek J; Kwiatkowska-Borowczyk E; Amarowicz R; Murias M; Wierzchowski M; Jodynis-Liebert J
Biomed Pharmacother; 2014 May; 68(4):397-400. PubMed ID: 24768110
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol analogue 3,4,4',5-tetramethoxystilbene inhibits growth, arrests cell cycle and induces apoptosis in ovarian SKOV-3 and A-2780 cancer cells.
Piotrowska H; Myszkowski K; Ziółkowska A; Kulcenty K; Wierzchowski M; Kaczmarek M; Murias M; Kwiatkowska-Borowczyk E; Jodynis-Liebert J
Toxicol Appl Pharmacol; 2012 Aug; 263(1):53-60. PubMed ID: 22687606
[TBL] [Abstract][Full Text] [Related]
4. Role of CYP1A1 in the biological activity of methylated resveratrol analogue, 3,4,5,4'-tetramethoxystilbene (DMU-212) in ovarian cancer A-2780 and non-cancerous HOSE cells.
Piotrowska-Kempisty H; Klupczyńska A; Trzybulska D; Kulcenty K; Sulej-Suchomska AM; Kucińska M; Mikstacka R; Wierzchowski M; Murias M; Baer-Dubowska W; Kokot Z; Jodynis-Liebert J
Toxicol Lett; 2017 Feb; 267():59-66. PubMed ID: 28049037
[TBL] [Abstract][Full Text] [Related]
5. The Effect of 3'-Hydroxy-3,4,5,4'-Tetramethoxy -stilbene, the Metabolite of the Resveratrol Analogue DMU-212, on the Motility and Proliferation of Ovarian Cancer Cells.
Nowicki A; Skupin-Mrugalska P; Jozkowiak M; Wierzchowski M; Rucinski M; Ramlau P; Krajka-Kuzniak V; Jodynis-Liebert J; Piotrowska-Kempisty H
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32046103
[TBL] [Abstract][Full Text] [Related]
6. Different susceptibility of colon cancer DLD-1 and LOVO cell lines to apoptosis induced by DMU-212, a synthetic resveratrol analogue.
Piotrowska H; Myszkowski K; Amarowicz R; Murias M; Kulcenty K; Wierzchowski M; Jodynis-Liebert J
Toxicol In Vitro; 2013 Dec; 27(8):2127-34. PubMed ID: 24055891
[TBL] [Abstract][Full Text] [Related]
7. The Effect of 4'-hydroxy-3,4,5-trimetoxystilbene, the Metabolite of Resveratrol Analogue DMU-212, on Growth, Cell Cycle and Apoptosis in DLD-1 and LOVO Colon Cancer Cell Lines.
Jozkowiak M; Skupin-Mrugalska P; Nowicki A; Borys-Wojcik S; Wierzchowski M; Kaczmarek M; Ramlau P; Jodynis-Liebert J; Piotrowska-Kempisty H
Nutrients; 2020 May; 12(5):. PubMed ID: 32392733
[TBL] [Abstract][Full Text] [Related]
8. Enhanced biological activity of liposomal methylated resveratrol analog 3'-hydroxy-3,4,5,4'-tetramethoxystilbene (DMU-214) in 3D patient-derived ovarian cancer model.
Nowicki A; Wawrzyniak D; Czajkowski M; Józkowiak M; Pawlak M; Wierzchowski M; Rolle K; Skupin-Mrugalska P; Piotrowska-Kempisty H
Drug Deliv; 2022 Dec; 29(1):2459-2468. PubMed ID: 35892260
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol analog trans 3,4,5,4'-tetramethoxystilbene (DMU-212) mediates anti-tumor effects via mechanism different from that of resveratrol.
Ma Z; Molavi O; Haddadi A; Lai R; Gossage RA; Lavasanifar A
Cancer Chemother Pharmacol; 2008 Dec; 63(1):27-35. PubMed ID: 18286288
[TBL] [Abstract][Full Text] [Related]
10. Anticancer effects of the metabolic products of the resveratrol analogue, DMU-212: structural requirements for potency.
Androutsopoulos VP; Ruparelia KC; Papakyriakou A; Filippakis H; Tsatsakis AM; Spandidos DA
Eur J Med Chem; 2011 Jun; 46(6):2586-95. PubMed ID: 21497957
[TBL] [Abstract][Full Text] [Related]
11. Effect of resveratrol analogue, DMU-212, on antioxidant status and apoptosis-related genes in rat model of hepatocarcinogenesis.
Piotrowska H; Kujawska M; Nowicki M; Petzke E; Ignatowicz E; Krajka-Kuźniak V; Zawierucha P; Wierzchowski M; Murias M; Jodynis-Liebert J
Hum Exp Toxicol; 2017 Feb; 36(2):160-175. PubMed ID: 27048571
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol inhibits ovarian tumor growth in an in vivo mouse model.
Tan L; Wang W; He G; Kuick RD; Gossner G; Kueck AS; Wahl H; Opipari AW; Liu JR
Cancer; 2016 Mar; 122(5):722-9. PubMed ID: 26619367
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4'-tetramethoxystilbene.
Sale S; Verschoyle RD; Boocock D; Jones DJ; Wilsher N; Ruparelia KC; Potter GA; Farmer PB; Steward WP; Gescher AJ
Br J Cancer; 2004 Feb; 90(3):736-44. PubMed ID: 14760392
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of HPLC-MS/MS procedure for determination of 3,4,4',5-tetra-methoxystilbene (DMU-212) and its metabolites in ovarian cancer cells and culture medium.
Klupczynska A; Sulej-Suchomska AM; Piotrowska-Kempisty H; Wierzchowski M; Jodynis-Liebert J; Kokot ZJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():30-35. PubMed ID: 28582662
[TBL] [Abstract][Full Text] [Related]
15. Curcumin synergizes with resveratrol to inhibit colon cancer.
Majumdar AP; Banerjee S; Nautiyal J; Patel BB; Patel V; Du J; Yu Y; Elliott AA; Levi E; Sarkar FH
Nutr Cancer; 2009; 61(4):544-53. PubMed ID: 19838927
[TBL] [Abstract][Full Text] [Related]
16. Integrated genomics of ovarian xenograft tumor progression and chemotherapy response.
Stuckey A; Fischer A; Miller DH; Hillenmeyer S; Kim KK; Ritz A; Singh RK; Raphael BJ; Brard L; Brodsky AS
BMC Cancer; 2011 Jul; 11():308. PubMed ID: 21781307
[TBL] [Abstract][Full Text] [Related]
17. Heteroaromatic analogs of the resveratrol analog DMU-212 as potent anti-cancer agents.
Penthala NR; Thakkar S; Crooks PA
Bioorg Med Chem Lett; 2015 Jul; 25(14):2763-7. PubMed ID: 26022840
[TBL] [Abstract][Full Text] [Related]
18. Individual and Combined Treatments with Methylated Resveratrol Analogue DMU-214 and Gefitinib Inhibit Tongue Cancer Cells Growth via Apoptosis Induction and EGFR Inhibition.
Jozkowiak M; Dyszkiewicz-Konwinska M; Ramlau P; Kranc W; Spaczynska J; Wierzchowski M; Kaczmarek M; Jodynis-Liebert J; Piotrowska-Kempisty H
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34201116
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of the chemopreventive agent resveratrol and its synthetic analog trans 3,4,5,4'-tetramethoxystilbene (DMU-212) on adenoma development in the Apc(Min+) mouse and cyclooxygenase-2 in human-derived colon cancer cells.
Sale S; Tunstall RG; Ruparelia KC; Potter GA; Steward WP; Gescher AJ
Int J Cancer; 2005 Jun; 115(2):194-201. PubMed ID: 15688382
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling of DMU-212-induced apoptosis and anti-angiogenesis in vascular endothelial cells.
Miao Y; Cui L; Chen Z; Zhang L
Pharm Biol; 2016; 54(4):660-6. PubMed ID: 26428916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
